2q37 deletion syndrome
2q37 Deletion Syndrome
2q37 Deletion Syndrome is a rare genetic disorder caused by a deletion of a segment on the long arm (q) of chromosome 2. This condition is characterized by a variety of physical, developmental, and behavioral features.
Genetic Basis
2q37 Deletion Syndrome is caused by a deletion of genetic material on chromosome 2 at the q37 location. The size of the deletion can vary among individuals, leading to a range of symptoms. The syndrome is typically not inherited but occurs as a de novo mutation. However, in some cases, it can be inherited in an autosomal dominant manner if a parent carries a balanced translocation involving chromosome 2.
Clinical Features
Individuals with 2q37 Deletion Syndrome may present with:
- Developmental delay and intellectual disability
- Distinctive facial features, such as a prominent forehead, thin upper lip, and a flat nasal bridge
- Short stature
- Brachydactyly (short fingers and toes)
- Hypotonia (reduced muscle tone)
- Behavioral issues, including autism spectrum disorder and attention deficit hyperactivity disorder (ADHD)
Diagnosis
Diagnosis of 2q37 Deletion Syndrome is typically made through genetic testing, such as chromosomal microarray analysis or karyotyping, which can identify the deletion on chromosome 2. Clinical evaluation and assessment of symptoms also play a crucial role in diagnosis.
Management
There is no cure for 2q37 Deletion Syndrome, and treatment is symptomatic and supportive. Management may include:
- Early intervention programs and special education to address developmental delays
- Physical therapy to improve muscle tone and motor skills
- Behavioral therapy to manage behavioral issues
- Regular monitoring by a multidisciplinary team of healthcare providers
Prognosis
The prognosis for individuals with 2q37 Deletion Syndrome varies depending on the severity of symptoms and the size of the deletion. With appropriate support and interventions, many individuals can lead fulfilling lives.
Related Pages
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian